通过CancerTYPE ID诊断出任何胰胆管亚型,然后进行IDH1/2突变分析,可使有资格接受IDH1/2靶向治疗的患者数量增加1.8倍。同样,通过CancerTYPE ID结合IDH1/2突变分析诊断出胆管癌,可使有资格接受FDA批准的靶向治疗的患者数量增加5倍以上。 在某些病例中,基因突变是在没有FDA批准的靶向治疗方案的情况下发现的。例如,26.7%...
CancerTYPE ID已经在临床诊断原发灶不明癌症患者中表现出很好的优势。 对于诊断不明的患者,CancerTYPE ID是全球唯一一项可以明确原发灶不明转移癌的技术: CancerTYPE ID在检测患者中,改变了接近50%的患者的治疗方案。 CancerTYPE ID在每四个检测患者中,会有一个患者明确原来没有考虑过的原发灶。 常见问题 一、C...
CancerTYPE ID, performed by Biotheranostics, Inc., helps identify the tumor type and subtype for metastatic cancer patients with unclear diagnoses.Provider Portal Overview Clinical Data Order/Contact References Biotheranostics, Inc., A Hologic Company6333 Sequence Dr.,San Diego, CA 921211 (877) ...
CancerTYPE ID, performed by Biotheranostics, Inc., helps identify the tumor type and subtype for metastatic cancer patients with unclear diagnoses. Provider Portal Overview Clinical Data Order/Contact References Biotheranostics, Inc., A Hologic Company ...
CancerTYPE ID in the ClinicRalph V. Boccia
A multitude of proteins are aberrantly expressed in cancer cells, including the oncogenic serine-threonine kinase CK2. In a previous report, we found increases in CK2 transcript expression that could explain the increased CK2 protein levels found in tumors from lung and bronchus, prostate, breast,...
Gastric cancer (GC) remains a major cause of mortality despite declining rate in the world. Epigenetic alterations contribute significantly to the development and progression of gastric tumors. Epigenetic refers to the number of modifications of the chromatin structure that affect gene expression without...
This study identified common genes associated with various primary cancers, including prostate cancer, and established a predictive model to accurately forecast the likelihood of cancer occurrence and its specific type. The aim is to offer physicians assistance in treatment decisions and meticulous follow...
With the developments of DNA sequencing technology, large amounts of sequencing data have become available in recent years and provide unprecedented opportunities for advanced association studies between somatic point mutations and cancer types/subtypes, which may contribute to more accurate somatic point ...
Background Atrophic body gastritis (ABG) is associated with both type I gastric carcinoids (T1-GCs) and intestinal-type gastric cancer. The occurrence of gastric cancer in ABG patients with type I gastric carcinoids has not yet been described. Aim To describe the occurrence at follow-up of ...